Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea

Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea

OBJECTIVES Many countries have authorized the emergency use of oral antiviral agents for patients with mild-to-moderate cases of coronavirus disease 2019 (COVID-19). We assessed the cost-effectiveness of these agents for reducing the number of severe COVID-19 cases and the burden on Korea’s medical...

Full description

Bibliographic Details
Main Authors: Youngji Jo, Sun Bean Kim, Munkhzul Radnaabaatar, Kyungmin Huh, Jin-Hong Yoo, Kyong Ran Peck, Hojun Park, Jaehun Jung
Format: Article
Language:English
Published: Korean Society of Epidemiology 2022-03-01
Series:Epidemiology and Health
Subjects:
sars-cov-2
cost-effectiveness analysis
antiviral agents
covid-19
hospitalization
Online Access:http://www.e-epih.org/upload/pdf/epih-44-e2022034.pdf

Internet

http://www.e-epih.org/upload/pdf/epih-44-e2022034.pdf

Similar Items